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Purpose or Objective: In MRI guided radiotherapy (e.g. MR-
linac), radiation is delivered in presence of a magnetic field. 
Therefore, the dose deposition is different since the path of 
the secondary electrons is changed due to the Lorentz force. 
Especially at air-tissue interfaces this causes changes in dose 
distribution. An example is the change in reading of a 
ionization chamber in a magnetic field. Besides, since the 
electrons are bend, the net effect is that electrons will travel 
less in forward direction, as a result the local dose deposition 
will change slightly even in an area with homogenous density. 
How to account for these changes in the various codes of 
practice for reference dosimetry is yet under debate. The 
purpose of this abstract is to quantify the change in dose-to-
water (for a fixed setup) when applying a magnetic field. 
 
Material and Methods: The Monte Carlo (MC) dose engine 
from Monaco TPS (Elekta) was used to estimate the change in 
dose-to-water. Validation of this MC code against other 
established MC codes has been performed by other research 
groups. For different square field sizes (from 5 to 30 cm) the 
dose deposition of a 6MV photon beam of an Elekta Agility 
linac is calculated in a water phantom of 50x50x40 cm3 (SAD 
= 100 cm, SSD = 90 cm). Calculations were performed with 
and without a transversal 1.5T magnetic field for the same 
number of MU. MC variance was 0.1%. Difference in dose was 
calculated by means of the percentage difference in depth 
dose in a volumetric region below dose maximum and above 
phantom bottom (5<depth<35 cm) and around the central 
axis. A histogram of the percentage differences was 
calculated for all field sizes. Subsequently, a Gaussian 
function is fitted to the peak region of the histogram (central 
part) to reduce the binning effects. 
 
Results: In figure (a) an example of a depth dose curve (and 
close up) with and without magnetic field is shown for field 
size 10x10 cm2. Figure (b) shows the percentage difference 
for all square field sizes (9 sample point per field size). The 
mean percentage difference for all field sizes ranges 
between -0.4% and 0.55%. 
 
 
These results show, within the MC variance, that a tendency 
is visible over the different field sizes. This may be caused by 
the change in phantom scatter for different field sizes. 
However, the MC variation causes large variation in the ratio. 
For small field sizes (<5x5 cm2) penumbra effects will come 
into play and are for that reason disregarded. The effect of 
beam hardening is neglected in this work.  
 
Conclusion: A difference in dose-to-water can be estimated 
as -0.45% for a 10x10 cm2 field, which is related to the fact 
that the electrons travel less in forward direction. Note that 
this dose difference can also be expressed as a shift in PDD 
(in the order of a mm). Depending on the used code of 
practice for reference dosimetry, this difference needs to be 
taken into account when applying correction factors for 
magnetic field effects. 
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Purpose or Objective: Time-efficient dose delivery by 
volumetric modulated arc therapy (VMAT) for stereotactic 
body radiation therapy (SBRT) is gaining more and more 
interest in radiation oncology. The combination of VMAT with 
potentially-lethal SBRT doses in heterogeneous tissue 
circumstances has led to an emerging use of anthropomorphic 
phantoms for quality assurance (QA) of both therapeutic 
target dose coverage and organ-at-risk (OAR) sparing. In this 
study, the first evaluation worldwide of a new-generation 
anthropomorphic phantom (E2E SBRT phantom model 036A 
CIRS INC., Norfolk, VA) was conducted for dose delivery of 
spine and lung SBRT using VMAT. 
 
Material and Methods: The phantom mimics the thorax 
anatomy with lung-tissue surrounded by rib structures and 
vertebrae, allowing appropriate image-guidance with a 
subsequent anthropomorphic dose evaluation. The phantom 
was customized to fit an Exradin A1SL (Standard Imaging, 
Middleton, WI) ionization chamber (IC) in the tumor centroid 
and in the peripheral lung. Also TLD or alanine pellets 
cutouts are foreseen in the phantom. In thoracic and pelvic 
part of the phantom, both an axial and coronal plane are 
available for comparing calculated and measured film dose in 
the target area. A lung insert with a kidney-shaped tumor 
was specifically developed to verify VMAT lung SBRT with film 
and IC. The kidney-shaped lung tumor also allowed for a dose 
film evaluation of the isodose levels along both the medial 
concave and lateral convex border of the tumor. External 
markings on the insert allowed to simulate the influence of a 
rotational tumor offset (step size 1°) with respect to the 
planning CT. 
 
Results: To already illustrate the potential of the phantom, 
initial QA results obtained from the new phantom for a spine 
SBRT and a lung lesion with VMAT SBRT were visualized in 
Figure 1A and 1B. Overall, a good agreement was found 
between dose calculation of the treatment planning system 
and respectively film (>88%) (absolute dose) and IC (<3%) 
measurements. The difference in agreement score for an OAR 
close to respectively the concave or convex border of the 
tumor was similar (see Figure 1B). With 2 and 5 mm PTV 
margins for respectively spine and lung SBRT, up to 1° and 3° 
rotation of the phantom insert led to an adequate target 
coverage. 
 
